Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
A randomized double blind clinical trial to assess efficacy of leflunomide in treatment of refractory juvenile idiopathic arthritis. Patients are randomly divided into two groups. In group 1 leflunomide and in group 2 placebos will be added to conventional treatment for three months. therapeutic responses will be evaluated by ACRpedi (American College of Rheumatology Pediatric) scores every 4 weeks.
Epistemonikos ID: 635dfa7d935de7aab2929680ea258964f9d1a3b1
First added on: May 11, 2024